JAK2 and cancer: This overall network of interactions underscores the biological significance of pathways like MAPK/ERK and JAK-STAT, with proteins such as MAPK3, RAF1, and JAK2 serving as potential therapeutic targets for diseases in which these signaling pathways are dysregulated, such as cancer and inflammatory diseases.